Genome Partnership Inc

Genome Partnership Inc, located in Saint Louis, MO, is a leading organization dedicated to advancing precision health and genomic research. With a focus on biotech innovation and collaboration, they strive to accelerate the discovery of treatments for rare neurodegenerative diseases and other genetic conditions. Through their research strategy and outcome measures, Genome Partnership Inc aims to integrate community-driven initiatives and patient family experiences into every aspect of their work, ultimately bringing urgently needed treatments to children and individuals affected by these conditions. The team at Genome Partnership Inc includes renowned experts in the field, such as Luke Rosen, who founded KIF1A.ORG to accelerate the discovery of treatments for rare neurodegenerative diseases. They also collaborate with Alexandre Reymond, a leading researcher in genome structural changes and their impact on gene expression, and Michael Schatz, a distinguished professor specializing in computational genomics research. With their expertise and dedication, Genome Partnership Inc is at the forefront of advancing precision health and making significant contributions to the understanding of genomes for medical and agricultural purposes.

Generated from the website